SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING -- Ignore unavailable to you. Want to Upgrade?


To: pat w. who wrote (23)3/18/1998 10:39:00 PM
From: Mark T. Heath  Read Replies (1) | Respond to of 142
 
Ironically, I'm going to my dentist for a cleaning in the morning. We've discussed CGPI in the past as he is aware of the company and the treatment they are seeking to get FDA approval on. He said the marketplace is huge for such a product. I'll inquire of him some more on the disease and see what else he thinks.

Has anyone seen either or both of the brokerage reports by the guys who currently have CGPI as a buy? I'd be curious to hear the revenue projections on the product.



To: pat w. who wrote (23)4/18/1998 2:10:00 AM
From: thomas larkin  Respond to of 142
 
Are there any other trials they are working on besides periostat? I read a projected 18 to 23 dollar value in a year. Shouldn't this stock be moving up gradually. I know it went up to 11 over night but dropped back down, any reason?